CAMBRIDGE, Mass., Aug 13, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (Nasdaq: ALKS) will host a conference call at 4:30pm ET on Wednesday, August 14, 2002, to discuss the Company's financial results for the first quarter. Management will review the quarter and provide an update on the company.
The conference call may be accessed by dialing 1-888-689-9339 for domestic callers and 1-334-323-2940 for international callers. The passcode is 6512#. Additionally, the call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com and archived on the site until Monday, August 19, 2002 at 5:00 pm.
A replay of the conference call will be available from 7:00pm ET on August 14, 2002 through 5:00 pm EDT on August 19, 2002, and may be accessed by visiting Alkermes' website or by dialing 1-888-258-7854 for domestic callers and 1-703-925-2490 for international callers. The passcode is 36210.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. The Company has several areas of focus including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks using its ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on its proprietary AIR(TM) pulmonary technology. In addition to the Company's Cambridge, Massachusetts headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT:
Alkermes, Inc.
Rebecca Peterson, 617/583-6378
Copyright (C) 2002 Business Wire. All rights reserved.